![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 487/04 | |
C07D 471/04 | |||
C07D 513/04 | |||
A61K 31/5025 | |||
A61P 35/00 |
(11) | Number of the document | 2892904 |
(13) | Kind of document | T |
(96) | European patent application number | 13832587.3 |
Date of filing the European patent application | 2013-08-01 | |
(97) | Date of publication of the European application | 2015-07-15 |
(45) | Date of publication and mention of the grant of the patent | 2018-10-17 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/CN2013/080598 |
Date | 2013-08-01 |
(87) | Number | WO 2014/032498 |
Date | 2014-03-06 |
(30) | Number | Date | Country code |
201210322359 | 2012-09-03 | CN |
(72) |
ZHONG, Boyu, CN
SHIH, Chuan, CN
YUAN, Hongbin, CN
ZHOU, Feng, CN
|
(73) |
CB Therapeutics Inc.,
c/o Codan Trust Company (Cayman) Limited Boundary Hall, 2nd Floor Cricket Square, PO Box 2681, Grand Cayman KY1-1111,
KY
|
(54) | HIGHLY SELECTIVE C-MET INHIBITORS AS ANTICANCER AGENTS |
HIGHLY SELECTIVE C-MET INHIBITORS AS ANTICANCER AGENTS |